3076
X. Shang et al. / Tetrahedron 70 (2014) 3073e3077
122.8, 69.5, 69.4, 44.8, 21.4, 21.1, 15.0; ESI-MS: m/z¼359.0 (positive
ion, MeOH), m/z¼127.1 (negative ion, MeOH); IR (neat): 2987, 2901,
2H), 7.02 (t, J¼8.0 Hz, 1H), 6.64 (s, 1H), 5.19 (s, 1H), 3.78 (s, 9H); 13
C
NMR (100 MHz, CDCl3):
d 170.5, 140.9, 132.0, 123.5, 121.9, 120.9,
1707, 1375, 1241, 1106, 1071 cmꢁ1
.
116.6, 116.0, 109.8, 104.7, 73.7, 52.7, 47.9, 34.5; IR (neat): 2987, 2901,
1727, 1250, 1066, 1056 cmꢁ1; MS (EI): m/z (%): 300 (Mþ, 20), 241
4.2.6. 1-(2-(3-(tert-Butoxy)-2-(tert-butoxycarbonyl)-3-oxoprop-1-
(100), 181 (50); HRMS (EI-TOF) calcd for
300.1110, found: 300.1110.
C
16H16N2O4 (Mþ):
en-1-yl)phenyl)-3-methyl-1H-imidazol-3-ium iodide (2f). 1H NMR
(400 MHz, DMSO-d6):
7.69e7.76 (m, 3H), 7.58e7.64 (m, 1H), 7.40 (s, 1H), 3.98 (s, 3H), 1.45
(s, 9H), 1.41 (s, 9H); 13C NMR (100 MHz, DMSO-d6):
163.9, 161.8,
d 9.54 (s, 1H), 7.99 (s, 1H), 7.88 (s, 1H),
4.5.2. Diethyl
2-(1-methyl-1H-imidazo[1,2-a]indol-9-yl)malonate
d
(3c). Green solid, mp¼135e138 ꢀC, yield: 74%. 1H NMR (400 MHz,
138.0, 134.7, 133.5, 133.3, 131.4, 130.8, 129.3, 129.2, 127.0, 124.2,
123.5, 82.8, 82.4, 36.3, 27.6, 27.4; ESI-MS: m/z¼385.0 (positive ion,
MeOH), m/z¼127.0 (negative ion, MeOH); IR (neat): 2987, 2901,
CDCl3):
d
7.56 (d, J¼8.4 Hz, 1H), 7.49 (d, J¼8.0 Hz, 1H), 7.15e7.26 (m,
2H), 6.98 (t, J¼7.6 Hz, 1H), 6.60 (d, J¼2.0 Hz, 1H), 5.11 (s, 1H),
4.13e4.29 (m, 4H), 3.75 (s, 3H), 1.26 (t, J¼7.2 Hz, 6H); 13C NMR
1704, 1394, 1249, 1067 cmꢁ1
.
(100 MHz, CDCl3): d 170.1, 140.9, 132.1, 123.6, 121.9, 120.8, 116.9,
115.9, 109.7, 104.7, 74.0, 61.6, 48.4, 34.6, 14.1; IR (neat): 2987, 2901,
1741, 1714, 1255, 1057, 1028 cmꢁ1; MS (EI): m/z (%): 328 (Mþ, 29),
255 (100), 227 (55), 181 (38); HRMS (EI-TOF) calcd for C18H20N2O4
(Mþ): 328.1423, found: 328.1425.
4.2.7. 1-(2-(3-Methoxy-2-(methoxycarbonyl)-3-oxoprop-1-en-1-yl)
phenyl)-3-methyl-1H-benzo[d]imidazol-3-ium iodide (2g). 1H NMR
(400 MHz, DMSO-d6):
d
10.06 (s, 1H), 8.17 (d, J¼8.0 Hz, 1H),
7.75e7.87 (m, 4H), 7.65e7.73 (m, 1H), 7.57e7.64 (m, 2H), 7.46 (d,
J¼8.4 Hz, 1H), 4.21 (s, 3H), 3.76 (s, 3H), 3.65 (s, 3H); 13C NMR
4.5.3. Diisopropyl 2-(1-methyl-1H-imidazo[1,2-a]indol-9-yl)malo-
(100 MHz, DMSO-d6):
d
165.3, 163.0, 144.3, 138.4, 132.1, 131.7, 131.6,
nate (3d). Green solid, mp¼120e125 ꢀC, yield: 91%. 1H NMR
131.5, 130.3, 129.6, 129.3, 128.4, 127.3, 126.9, 114.1, 113.0, 52.9, 52.9,
33.6; ESI-MS: m/z¼351.0 (positive ion, MeOH), m/z¼127.0 (nega-
tive ion, MeOH); IR (neat): 2987, 2901, 1719, 1406, 1394, 1241,
(400 MHz, CDCl3):
d
7.56 (d, J¼8.0 Hz, 1H), 7.47 (d, J¼8.4 Hz, 1H),
7.12e7.26 (m, 2H), 6.97 (t, J¼7.6 Hz, 1H), 6.60 (d, J¼2.0 Hz, 1H),
4.99e5.11 (m, 3H), 3.75 (s, 3H), 1.18e1.30 (m, 12H); 13C NMR
1067 cmꢁ1
.
(100 MHz, CDCl3): d 169.6, 141.0, 132.2, 123.6, 121.9, 120.6, 117.2,
115.8, 109.6, 104.7, 74.1, 69.1, 49.0, 34.7, 21.6; IR (neat): 2986, 2924,
1723, 1568, 1096 cmꢁ1; MS (EI): m/z (%): 356 (Mþ, 23), 269 (63), 227
(100),181 (39), 149 (22); HRMS (EI-TOF) calcd for C20H24N2O4 (Mþ):
356.1736, found: 356.1739.
4.3. General procedure for synthesis of 2ac
To the saturated solution of ammonium hexafluorophosphate
(5.0 equiv), imidazolium or imidazolium halide dissolved in water
was added slowly, the white precipitate was produced immedi-
ately. The product was filtrated and dried.
4.5.4. Diisopropyl 2-(1-ethyl-1H-imidazo[1,2-a]indol-9-yl)malonate
(3e). Brown oil, yield: 81%. 1H NMR (400 MHz, CDCl3):
d 7.62 (d,
2ac: 1H NMR (400 MHz, DMSO-d6):
d
9.50 (s, 1H), 7.94 (s, 2H),
7.69e7.76 (m, 3H), 7.64 (s, 1H), 7.50e7.53 (m, 1H), 3.97 (s, 3H), 3.77
(s, 3H), 3.70 (s, 3H); 13C NMR (100 MHz, DMSO-d6):
165.1, 163.1,
J¼8.0 Hz, 1H), 7.48 (d, J¼8.0 Hz, 1H), 7.13e7.26 (m, 2H), 6.97 (t,
J¼7.6 Hz, 1H), 6.67 (s, 1H), 5.00e5.13 (m, 2H), 5.00 (s, 1H), 4.10 (q,
J¼7.2 Hz, 2H), 1.44 (t, J¼7.2 Hz, 3H), 1.15e1.35 (m, 12H); 13C NMR
d
138.1, 137.7, 133.6, 131.7, 131.0, 129.9, 129.0, 128.8, 127.0, 124.2, 123.7,
53.0, 52.8, 36.1; ESI-MS: m/z¼300.9 (positive ion, CH3CN), m/
z¼144.8 (negative ion, CH3CN); IR (neat): 2987, 2901, 1406, 1394,
(100 MHz, CDCl3): d 169.0, 140.2, 131.9, 123.8, 120.6, 119.3, 118.2,
115.8, 109.5, 105.0, 73.9, 69.0, 49.2, 42.0, 21.7, 21.6, 15.1; IR (neat):
2979, 1720, 1574, 1098 cmꢁ1; MS (EI): m/z (%): 370 (Mþ, 37), 283
(81), 241 (100),195 (42); HRMS (EI-TOF) calcd for C21H26N2O4 (Mþ):
370.1893, found: 370.1888.
1250, 1229, 1066, 1056 cmꢁ1
.
4.4. General procedure for synthesis of 2ad
4.5.5. Di-tert-butyl 2-(1-methyl-1H-imidazo[1,2-a]indol-9-yl)malo-
To the saturated solution of sodium fluoroborate (5.0 equiv),
imidazolium or benzoimidazolium salt dissolved in water was
added slowly, the white precipitate was produced immediately. The
pure product was obtained after filtration and drying.
nate (3f). Green solid, mp¼107e109 ꢀC, yield: 63%. 1H NMR
(400 MHz, CDCl3):
d
7.60 (d, J¼8.0 Hz, 1H), 7.49 (d, J¼7.6 Hz, 1H),
7.23 (d, J¼0.8 Hz, 1H), 7.18 (t, J¼8.0 Hz, 1H), 6.98 (t, J¼7.6 Hz, 1H),
6.63 (s, 1H), 4.96 (s, 1H), 3.79 (s, 3H), 1.49 (s, 18H); 13C NMR
2ad: 1H NMR (400 MHz, DMSO-d6):
d
9.48 (s, 1H), 7.93 (s, 2H),
7.71e7.76 (m, 3H), 7.64 (s, 1H), 7.62 (d, J¼7.2 Hz, 1H), 3.96 (s, 3H),
3.77 (s, 3H), 3.70 (s, 3H); 13C NMR (100 MHz, DMSO-d6):
165.1,
(100 MHz, CDCl3): d 169.3, 132.3, 129.8, 128.1, 121.9, 120.5, 117.6,
115.7, 115.5, 109.5, 104.6, 81.5, 50.7, 34.8, 29.7, 28.0, 27.7; IR (neat):
2974, 2923, 1738, 1720, 1126, 1066 cmꢁ1; MS (EI): m/z (%): 384 (Mþ,
81), 283 (28), 227 (100), 183 (72); HRMS (EI-TOF) calcd for
d
163.1, 138.1, 137.7, 133.6, 131.8, 131.0, 130.0, 129.0, 128.9, 127.0, 124.2,
123.8, 53.0, 52.8, 36.2; ESI-MS: m/z¼300.9 (positive ion, CH3CN), m/
z¼87.2 (negative ion, CH3CN), IR (thin film): 2987, 2901, 1706, 1406,
C
22H28N2O4 (Mþ): 384.2049, found: 384.2048.
1193, 1051 cmꢁ1
.
4.5.6. Dimethyl
2-(10-methyl-10H-benzo[4,5]imidazo[1,2-a]indol-
11-yl)malonate (3g). Green solid, mp¼124e126 ꢀC, yield: 68%. 1H
4.5. General procedure for synthesis of 3aeg
NMR (400 MHz, CDCl3):
d
7.71 (d, J¼8.0 Hz, 1H), 7.65 (d, J¼8.0 Hz,
1H), 7.53 (d, J¼8.0 Hz, 1H), 7.03e7.22 (m, 5H), 5.13 (s, 1H), 3.74 (s,
Silver carbonate (0.5 equiv) was added to the solution of 2
(0.5 mmol) in water (2.5 mL) at 65 ꢀC under nitrogen in the Schlenk
tube. The mixture was stirred for 18 h. After the completion of the
reaction detected by TLC, it was extracted by ethyl acetate. The
combined organic extracts were dried over anhydrous Na2SO4 and
evaporated under reduced pressure. The product was purified by
column chromatography.
3H), 3.70 (s, 6H); 13C NMR (100 MHz, CDCl3):
d
170.0, 142.6, 138.3,
132.5, 127.1, 125.8, 122.3, 121.3, 120.1, 118.4, 117.2, 110.3, 109.9, 107.9,
76.4, 52.8, 47.8, 31.0; IR (neat): 2987, 2901, 1731, 1255, 1066,
1055 cmꢁ1; MS (EI): m/z (%): 350 (Mþ, 63), 291 (100), 233 (42);
HRMS (EI-TOF) calcd for C20H18N2O4 (Mþ): 350.1267, found:
350.1272.
Acknowledgements
4.5.1. Dimethyl 2-(1-methyl-1H-imidazo[1,2-a]indol-9-yl)malonate
(3a). Green solid, mp¼111e116 ꢀC, yield: 78%. 1H NMR (400 MHz,
We thank the financial support from the National Nature
Science Foundation of China (21352002).
CDCl3):
d
7.57 (d, J¼8.0 Hz, 1H), 7.52 (d, J¼8.0 Hz, 1H), 7.19e7.29 (m,